Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.53K Sell
24
-2
-8% -$569 ﹤0.01% 477
2026
Q1
$4.51K Buy
26
+2
+8% +$410 ﹤0.01% 541
2025
Q4
$6.15K Buy
+24
New +$6.29K ﹤0.01% 362
2024
Q1
Sell
-6
Closed -$2.75K 674
2023
Q4
$2.75K Buy
6
+2
+50% +$986 ﹤0.01% 574
2023
Q3
$1.95K Buy
+4
New +$1.88K ﹤0.01% 278

Other funds holding HUM

Arlington Trust's HUM Position: Q2 2026 in Review

Arlington Trust reduced its Humana (HUM) stake by 7.7% in Q2 2026, selling an estimated $569 and leaving 24 shares worth $9.53K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Arlington Trust first reported a position in HUM in Q3 2023 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Arlington Trust held 24 shares of Humana worth $9.53K as of Q2 2026.
  • Arlington Trust sold 2 Humana shares in Q2 2026, an estimated $569.
  • Humana made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #477 holding.
  • Arlington Trust first reported a position in Humana in Q3 2023 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.